PYC THERAPEUTICS LIM

PYC
End-of-day quote. End-of-day quote  - 01/19
0.15AUD -3.23%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
PYC Therapeutics Limited, formerly Phylogica Limited, is a pharmaceutical company. The Company is engaged combining its cell-penetrating peptides (CPP) technology with in ASOs to create a pipeline of drugs called CPP-ASOs. The Company intends to expand its pipeline to include other disease indications and therapeutic areas such as genetic neurodegenerative and liver diseases. Its pipeline products is Ocular, which is focused on treating retinitis pigmentosa and inherited retinal disease.
Managers
Name Title
Rohan Hockings Chief Executive Officer & Director
Alan W. Tribe Non-Executive Chairman
Kevin Hart Chief Financial Officer & Secretary
May Orfali Chief Medical Officer
Sue Fletcher Chief Scientific Officer
Bernard Hockings Non-Executive Director
Sahm Nasseri Director & Chief Executive Officer-US Operations
Douglas Huey Managing Director-US Operations
Kaggen Ausma Chief Business Officer
Shareholders
Name Equities %
Australia Land Pty Ltd. 970,820,136 30.1%
Bernard Hockings 265,617,507 8.24%
Anthony Peter Barton 180,081,427 5.58%
Sietsma Holdings Pty. Ltd. 167,200,000 5.18%
Masali Pty Ltd. 116,796,241 3.62%
McCusker Holdings Pty Ltd. 57,926,995 1.80%
Barton & Barton Pty Ltd. 47,911,669 1.49%
John Baird 41,304,466 1.28%
Datamatch Pty Ltd. 39,404,644 1.22%
Custom Binders Pty Ltd. 34,252,484 1.06%
Company contact information
PYC Therapeutics Ltd.
6 Verdun Street
Nedlands, Western Australia (WA) 6009

Phone : +61.8.6151.0992
Web : http://www.phylogica.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capi. (M$)
PYC THERAPEUTICS LIMITED1.69%366
MODERNA, INC.24.10%51 304
LONZA GROUP AG2.46%48 618
CELLTRION, INC.-12.95%38 786
IQVIA HOLDINGS INC.4.81%36 004
SEAGEN INC.6.06%33 601
HANGZHOU TIGERMED CONSULTING CO.,LTD-1.58%21 572
INCYTE CORPORATION4.12%19 832
ALNYLAM PHARMACEUTICALS, INC.28.00%19 328
PHARMARON BEIJING CO., LTD.4.15%15 388
CRISPR THERAPEUTICS AG30.55%14 233
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.9.55%13 616
BIO-TECHNE CORPORATION9.50%13 425
PPD, INC.6.66%12 762
QIAGEN N.V.0.66%12 098
ICON PUBLIC LIMITED COMPANY7.88%11 101
IONIS PHARMACEUTICALS, INC.8.38%8 568
ACADIA PHARMACEUTICALS INC.0.37%8 531
PRA HEALTH SCIENCES, INC.4.30%8 393
SYNEOS HEALTH, INC.10.70%7 838
UNITED THERAPEUTICS CORPORATION13.85%7 680